Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions

NCT03051711 is registered in ClinicalTrials.gov with Global Blood Therapeutics as lead sponsor.

NCT NCT03051711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03051711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions
Lead sponsor
Global Blood Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2016
Completion date
February 21, 2018
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardio-pulmonary function